Sanofi India to collaborate with NIPER Kolkata for pharma education and R&D

Two sides will be collaborate in the areas of pharmaceuticals and consumer healthcare products to cater to the current and future needs of the industry

Sanofi's research center at Chilly-Mazarin in France
Sanofi's research center at Chilly-Mazarin in France
BS B2B Bureau New Delhi
Last Updated : Nov 18 2016 | 11:47 AM IST
Sanofi India has signed a memorandum of understanding with National Institute of Pharmaceutical Education and Research (NIPER) Kolkata - an autonomous body set up under the Department of Pharmaceuticals, Government of India - to promote academic excellence and research. Two sides will be collaborate in the areas of pharmaceuticals and consumer healthcare products to cater to the current and future needs of the pharmaceutical industry.

Through this initiative, Sanofi India will participate in revision or formulation of curriculum for a post-graduate (MS) & Ph D programme, and undertake collaborative research activities in identified areas.

"The era of academic-industry collaboration to address the mammoth task of capacity building to meet our healthcare challenges has well and truly begun. Only a well-equipped and trained workforce can face future challenges and cater to the vast healthcare needs of the nation. We are proud to associate with NIPER Kolkata in this collaborative exercise to hone the students' skill-sets, and empower them for future, based on our practical knowledge and research experience," said Dr Shailesh Ayyangar, managing director, Sanofi India Ltd.

As per the MoU, the key deliverables for Sanofi India will be to assist NIPER Kolkata foster students with updated knowledge, and who are ready for the pharmaceutical industry. The collaboration will focus in the areas of NIPER Kolkata's expertise such as novel small molecules for anti-diabetics & drug resistant tuberculosis (TB), API by synthetic biology & cell factory, phyto-pharmaceuticals, etc.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 18 2016 | 11:44 AM IST

Next Story